Poseida Therapeutics (PSTX) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.53
-0.44
-0.34
-0.25

Details

Expected EPS
-0.42
Actual EPS
-0.25
Surprise EPS
0.17
Surprise Percent
+40.48%

Description

Poseida Therapeutics (PSTX) has reported earnings of -0.25 per share for Q2 2024.

0 Comments

Share your thoughts